Natural Capsules Ltd. Share Price & Stock Analysis

Natural Capsules Ltd. (BSE: 524654) is a Bengaluru, Karnataka-based company in the Pharmaceuticals industry. With a market capitalisation of ₹162 Cr, it ranks #2,823 by market cap among the 6,197 Indian listed companies on FinBizNet, and #40 of 63 in Pharmaceuticals. At ₹155.00 (as of 16 Nov 2026), the share price is 33.8% below its 52-week high of ₹234.00 and 18.2% above its 52-week low of ₹131.16. The share price is down 25.5% over one year and up 3.5% over three months.

Key Metrics

Current Price₹155.00
Market Cap₹162 Cr
BSE Code524654
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E RatioNot meaningful (loss)
Return on Equity-10.03%
Return on Assets-3.02%
52-Week Range₹131.16 – ₹234.00
1-Year Price Change-25.5%
3-Month Price Change+3.5%
Beta (1Y)0.76
Dividend Yield0.00%
HeadquartersBengaluru, Karnataka
Websitewww.naturalcapsules.com

Latest Quarterly Results — Q2 FY27

Revenue₹51 Cr
Net Profit₹-4 Cr
Net Margin-8.3%
EPS (Basic)₹-4.08
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Natural Capsules Ltd. Quarterly Revenue and Profit Trend

Natural Capsules Ltd. reported revenue of ₹51 Cr in Q2 FY27, up 11.7% from ₹46 Cr in Q2 FY26 and up 5.0% from ₹49 Cr in Q1 FY27. It posted a net loss of ₹4 Cr for the quarter, against a net loss of ₹7 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹38 Cr (Q3 FY26) to ₹58 Cr (Q4 FY26). The company reported a net loss in 6 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹51 Cr−₹4 Cr−8.3%
Q1 FY27₹49 Cr−₹6 Cr−11.8%
Q4 FY26₹58 Cr−₹5 Cr−8.5%
Q3 FY26₹38 Cr−₹7 Cr−18.9%
Q2 FY26₹46 Cr−₹7 Cr−15.3%
Q1 FY26₹45 Cr−₹6 Cr−12.3%
Q4 FY25₹45 Cr₹1 Cr1.2%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 50.92% of Natural Capsules Ltd.'s shares as of Sept 2026, against 51.26% in Sept 2025 (−0.34 percentage points). Delivery averaged 79.5% of traded volume across 8 NSE sessions (3 Nov 2026 – 13 Nov 2026).

About Natural Capsules Ltd.

Natural Capsules Limited engages in manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy free gelatin, shiny gelatin, sodium lauryl sulfate free gelatin, halal certified gelatin, fast release gelatin, printed gelatin/cellulose, vegetarian, and enteric capsule shells. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form. Natural Capsules Limited was incorporated in 1993 and is based in Bengaluru, India.

Products and Services

1. Manufacture of Capsules-This segment manufactures hard capsules for pharmaceutical and dietary supplement industries. 2. Capsules-This segment manufactures hard gelatin capsule shells, hard cellulose capsule shells, and pharmaceutical dosage forms in capsule dosage form. 3. Segment Adjustment-0 4. Formulation-This segment is involved in formulating the pharmaceutical dosage forms in capsule dosage form, both pharma and neutraceutical products.

Business Segments

1. Capsules-92.8% 2. API-7.2%

Natural Capsules Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Natural Capsules Ltd.₹162 Crn/m-10.03%₹51 Cr-25.5%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Natural Capsules Ltd.?

Natural Capsules Ltd. is trading at ₹155.00, with a market capitalisation of ₹162 Cr.

Which sector does Natural Capsules Ltd. belong to?

Natural Capsules Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Natural Capsules Ltd.?

Natural Capsules Ltd. has a return on equity of -10.03%.

What is the stock symbol of Natural Capsules Ltd.?

Natural Capsules Ltd. is listed on the BSE under the scrip code 524654.

How has Natural Capsules Ltd.'s share price moved over the past year?

Natural Capsules Ltd.'s share price is down 25.5% over one year and up 3.5% over three months. Its 52-week range is ₹131.16 to ₹234.00.

What were Natural Capsules Ltd.'s latest quarterly results?

In Q2 FY27, Natural Capsules Ltd. reported revenue of ₹51 Cr and net profit of ₹-4 Cr, with basic EPS of ₹-4.08 (consolidated, parsed from the company's exchange filing).

How have Natural Capsules Ltd.'s revenue and profit changed over the past year?

Natural Capsules Ltd. reported revenue of ₹51 Cr in Q2 FY27, up 11.7% from ₹46 Cr in Q2 FY26 and up 5.0% from ₹49 Cr in Q1 FY27.

What is the promoter holding in Natural Capsules Ltd.?

Promoters held 50.92% of Natural Capsules Ltd.'s shares as of Sept 2026, against 51.26% in Sept 2025 (−0.34 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.